Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis.

IF 1.4 Q3 RHEUMATOLOGY Journal of Scleroderma and Related Disorders Pub Date : 2024-10-01 Epub Date: 2024-08-11 DOI:10.1177/23971983241264090
Jennifer Rossdale, John Graby, Maredudd Harris, Calum Jones, Davyd Greenish, Jessica Bartlett, Andrew Gilroy, Jamie Sanghera, John D Pauling, Sarah Skeoch, Victoria Flower, Rob Mackenzie Ross, Jay Suntharalingam, Jonathan Cl Rodrigues
{"title":"Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis.","authors":"Jennifer Rossdale, John Graby, Maredudd Harris, Calum Jones, Davyd Greenish, Jessica Bartlett, Andrew Gilroy, Jamie Sanghera, John D Pauling, Sarah Skeoch, Victoria Flower, Rob Mackenzie Ross, Jay Suntharalingam, Jonathan Cl Rodrigues","doi":"10.1177/23971983241264090","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Coronary artery calcification assessed on thoracic computed tomography represents the calcific component of established coronary artery disease, is a biomarker of total atheromatous plaque burden and predicts mortality. Systemic sclerosis is a pro-inflammatory condition, and inflammation is also a driver of coronary artery disease. We assessed coronary artery calcification prevalence, mortality risk and potential clinical impact on primary prevention in a cohort of patients with systemic sclerosis, differentiated by clinical phenotype including the presence of interstitial lung disease and pulmonary arterial hypertension.</p><p><strong>Methods: </strong>Retrospective analysis of 258 computed tomographies in systemic sclerosis patients from three prospectively maintained clinical and research databases at a single tertiary rheumatology/pulmonary hypertension (PH) service between March 2007 and September 2020 (mean age = 65 ± 12, 14% male). Co-morbidities, statin prescription and all-cause mortality were recorded. Patients were subtyped according to underlying systemic sclerosis complications. Computed tomographies were re-reviewed for coronary artery calcification; severity was graded using a 4-point scale per vessel and summed for total coronary artery calcification score. The impact of reporting coronary artery calcification was assessed against pre-existing statin prescriptions.</p><p><strong>Results: </strong>Coronary artery calcification was present in 58% (149/258). Coronary artery calcification was more prevalent in systemic sclerosis-pulmonary arterial hypertension than in systemic sclerosis subgroups with interstitial lung disease or without pulmonary arterial hypertension, controlling for age, sex, co-morbidities and smoking status (71%; <i>χ</i> <sup>2</sup>(13) = 81.4; <i>p</i> < 0.001). The presence and severity of coronary artery calcification were associated with increased risk of mortality independently of age and co-morbidities (hazard ratio = 2.8; 95% confidence interval = 1.2-6.6; <i>p</i> = 0.018). The 'number needed to report' coronary artery calcification presence to potentially impact management was 3.</p><p><strong>Conclusions: </strong>Coronary artery calcification is common in systemic sclerosis. Coronary artery calcification predicts mortality independently of age and confounding co-morbidities which suggests this finding has clinical relevance and is a potential target for screening and therapeutic intervention.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459481/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983241264090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Coronary artery calcification assessed on thoracic computed tomography represents the calcific component of established coronary artery disease, is a biomarker of total atheromatous plaque burden and predicts mortality. Systemic sclerosis is a pro-inflammatory condition, and inflammation is also a driver of coronary artery disease. We assessed coronary artery calcification prevalence, mortality risk and potential clinical impact on primary prevention in a cohort of patients with systemic sclerosis, differentiated by clinical phenotype including the presence of interstitial lung disease and pulmonary arterial hypertension.

Methods: Retrospective analysis of 258 computed tomographies in systemic sclerosis patients from three prospectively maintained clinical and research databases at a single tertiary rheumatology/pulmonary hypertension (PH) service between March 2007 and September 2020 (mean age = 65 ± 12, 14% male). Co-morbidities, statin prescription and all-cause mortality were recorded. Patients were subtyped according to underlying systemic sclerosis complications. Computed tomographies were re-reviewed for coronary artery calcification; severity was graded using a 4-point scale per vessel and summed for total coronary artery calcification score. The impact of reporting coronary artery calcification was assessed against pre-existing statin prescriptions.

Results: Coronary artery calcification was present in 58% (149/258). Coronary artery calcification was more prevalent in systemic sclerosis-pulmonary arterial hypertension than in systemic sclerosis subgroups with interstitial lung disease or without pulmonary arterial hypertension, controlling for age, sex, co-morbidities and smoking status (71%; χ 2(13) = 81.4; p < 0.001). The presence and severity of coronary artery calcification were associated with increased risk of mortality independently of age and co-morbidities (hazard ratio = 2.8; 95% confidence interval = 1.2-6.6; p = 0.018). The 'number needed to report' coronary artery calcification presence to potentially impact management was 3.

Conclusions: Coronary artery calcification is common in systemic sclerosis. Coronary artery calcification predicts mortality independently of age and confounding co-morbidities which suggests this finding has clinical relevance and is a potential target for screening and therapeutic intervention.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冠状动脉钙化是系统性硬化症的常见病,与不良预后有关。
目的:胸部计算机断层扫描评估的冠状动脉钙化代表已确诊冠状动脉疾病的钙化成分,是动脉粥样斑块总负荷的生物标志物,并可预测死亡率。系统性硬化是一种促炎症状态,而炎症也是冠状动脉疾病的驱动因素。我们评估了一组全身性硬化症患者的冠状动脉钙化发生率、死亡风险以及对一级预防的潜在临床影响,这些患者的临床表型包括间质性肺病和肺动脉高压:2007年3月至2020年9月期间,对一家三级风湿病学/肺动脉高压(PH)服务机构的三个前瞻性临床和研究数据库中的258例系统性硬化症患者的计算机断层扫描结果进行回顾性分析(平均年龄=65±12岁,14%为男性)。并发症、他汀类药物处方和全因死亡率均有记录。根据潜在的系统性硬化并发症对患者进行分型。对计算机断层扫描进行冠状动脉钙化复查;对每条血管的钙化严重程度采用 4 级评分法进行分级,并汇总得出冠状动脉钙化总分。评估了报告冠状动脉钙化对原有他汀类药物处方的影响:58%的患者(149/258)存在冠状动脉钙化。在控制了年龄、性别、合并疾病和吸烟状况后,系统性硬化症-肺动脉高压患者的冠状动脉钙化发生率高于有间质性肺病或无肺动脉高压的系统性硬化症亚组(71%;χ 2(13) = 81.4;P = 0.018)。需要报告 "冠状动脉钙化存在的人数 "对管理产生潜在影响的比例为 3.结论:结论:冠状动脉钙化在系统性硬化症中很常见。冠状动脉钙化可预测死亡率,不受年龄和并发症的影响,这表明这一发现具有临床意义,是筛查和治疗干预的潜在目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
31
期刊最新文献
Atypical morphoea, a herald of two malignancies: Lung adenocarcinoma and a neuroendocrine tumour. Changes in work and adequacy of financial resources during COVID-19 among people with systemic sclerosis: A Scleroderma Patient-centered Intervention Network study. Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis. N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional study. Views of nutrition needs in patients with systemic sclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1